FDA leaders say the agency will require more clinical trials to show the benefits of annual COVID shots for healthy adults.

The Food and Drug Administration will no longer approve COVID-19 vaccines for healthy people under 65 without rigorous trials ...

The US Food and Drug Administration will now require Covid-19 vaccines from Pfizer/BioNTech and Moderna to use expanded ...

As Covid-19 cases begin to rise again in several parts of the world, concerns regarding vaccine side effects have re-emerged.

The US Food and Drug Administration is changing the way it approves Covid-19 vaccines for Americans, a move that may limit ...

According to the CDC, cases of myocarditis and pericarditis are rare with the vaccines and in most cases resolve within a few ...

We have to admit to ourselves that America is deeply divided on the policy issue of repeat COVID-19 vaccine doses or boosters ...

In this week’s edition of InnovationRx, we look at the FDA's new rules on Covid-19 vaccines, Novartis’s acquisition strategy, ...

The FDA will now require clinical trials to approve boosters for healthy Americans under 65, making it unlikely the shots ...

The FDA plans to require new clinical trials for approval of annual COVID-19 boosters for healthy Americans under 65.

The FDA will narrow its approval for updated coronavirus vaccines, marking a significant shift in the agency’s approach to ...

Dr. Anil Diwan, President of NanoViricides, Inc. (NYSE Amer.:NNVC ) (the “Company”), comments on the new COVID Vaccine policy adopted by the US FDA.